Renaissance Technologies
CLOV icon

Renaissance Technologies’s Clover Health Investments CLOV Stock Holding History

Renaissance Technologies’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7M Sell
2,807,441
-594,100
-17% -$2.02M 0.02% 858
2026
Q1 		$5.99M Sell
3,401,541
-1,089,600
-24% -$2.36M 0.01% 1265
2025
Q4 		$10.6M Sell
4,491,141
-3,221,559
-42% -$8.81M 0.02% 891
2025
Q3 		$23.6M Sell
7,712,700
-2,780,900
-27% -$7.94M 0.03% 649
2025
Q2 		$29.3M Sell
10,493,600
-530,800
-5% -$1.75M 0.04% 553
2025
Q1 		$39.6M Sell
11,024,400
-42,200
-0.4% -$169K 0.06% 396
2024
Q4 		$34.9M Sell
11,066,600
-1,413,300
-11% -$5.05M 0.05% 440
2024
Q3 		$35.2M Buy
12,479,900
+1,207,600
+11% +$2.76M 0.05% 444
2024
Q2 		$13.9M Sell
11,272,300
-124,300
-1% -$112K 0.02% 759
2024
Q1 		$9.05M Sell
11,396,600
-1,190,100
-9% -$1.08M 0.01% 1043
2023
Q4 		$12M Buy
12,586,700
+2,179,400
+21% +$2.14M 0.02% 863
2023
Q3 		$11.2M Buy
10,407,300
+1,559,520
+18% +$1.86M 0.02% 860
2023
Q2 		$7.94M Buy
8,847,780
+1,999,380
+29% +$1.77M 0.01% 1152
2023
Q1 		$5.79M Buy
6,848,400
+2,446,000
+56% +$2.68M 0.01% 1389
2022
Q4 		$4.09M Buy
4,402,400
+421,700
+11% +$563K 0.01% 1638
2022
Q3 		$6.77M Buy
3,980,700
+2,351,160
+144% +$6.16M 0.01% 1256
2022
Q2 		$3.49M Buy
1,629,540
+674,740
+71% +$1.79M ﹤0.01% 1810
2022
Q1 		$3.39M Buy
+954,800
New +$2.77M ﹤0.01% 1845

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies's CLOV Position: Q2 2026 in Review

Renaissance Technologies reduced its Clover Health Investments (CLOV) stake by 17% in Q2 2026, selling an estimated $2.02M and leaving 2,807,441 shares worth $14.7M. The position accounts for 0.02% of the portfolio, ranked #858.

Renaissance Technologies first reported a position in CLOV in Q1 2022 and has held it in 18 quarters since. The position peaked at $39.6M in Q1 2025. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Renaissance Technologies held 2,807,441 shares of Clover Health Investments worth $14.7M as of Q2 2026.
  • Renaissance Technologies sold 594,100 Clover Health Investments shares in Q2 2026, an estimated $2.02M.
  • Clover Health Investments made up 0.02% of Renaissance Technologies's portfolio in Q2 2026, its #858 holding.
  • Renaissance Technologies first reported a position in Clover Health Investments in Q1 2022 and has held it in 18 quarters since.
  • Renaissance Technologies's Clover Health Investments position peaked at $39.6M in Q1 2025.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.